Hypoxia-induced angiogenesis during carcinogenesis

Journal of Biochemistry and Molecular Biology

Volumn 36, Issue 1, 2003, Pages 120-127

  Choi, Kyu Sil ^a   Bae, Moon Kyoung ^a   Jeong, Joo Won ^a   Moon, Hyo Eun ^a   Kim, Kyu Won ^a  

^a Seoul National University   (South Korea)

Author keywords

Angiogenesis; HIF 1 ; Hypoxia

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; OXYGEN; PROTEIN; PROTEIN JAB1; PROTEIN P300; PROTEIN P53; PROTEIN PVHL; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VASCULOTROPIN; DNA BINDING PROTEIN; ENDOTHELIAL CELL GROWTH FACTOR; HIF1A PROTEIN, HUMAN; LYMPHOKINE; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; VASCULOTROPIN A;

ACETYLATION; ANALYTIC METHOD; ANGIOGENESIS; CANCER THERAPY; CARCINOGENESIS; HUMAN; HYDROXYLATION; HYPOXIA; MOLECULAR DYNAMICS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION INITIATION; TUMOR; UBIQUITINATION; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; VASCULARIZATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037530130     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Ahmed, A., Dunk, C., Ahmad, S. and Khaliq, A. (2000) Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen-a review. Placenta 21 Suppl. A, S16-S24.
2. An, F. Q., Matsuda, M., Fujii, H. and Matsumoto, Y. (2000) Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 126, 153-160.
3. An, W. G., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V. and Neckers, L. M. (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392, 405-408.
4. Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F. and Livingston, D. M. (1996) An essential role for p300/CBP in the cellular response to hypoxia. Proc. Natl. Acad. Sci. USA 93, 12969-12973.
5. Bae, M. K., Ahn, M. Y., Jeong, J. W., Bae, M. H., Lee, Y. M., Bae, S. K., Park, J. W., Kim, K. R. and Kim, K. W. (2002) Jab1 interacts directly with HIF-1alpha and regulates its stability. J. Biol. Chem. 277, 9-12.
6. Bae, S. K., Bae, M. H., Ahn, M. Y., Son, M. J., Lee, Y. M., Bae, M. K., Lee, O. H., Park, B. C. and Kim, K. W. (1999) Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 59, 5989-5994.
7. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C. and Dubiel, W. (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20, 1630-1639.
8. Berra, E., Pages, G. and Pouyssegur, J. (2000) MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev. 19, 139-145.
9. Berra, E., Roux, D., Richard, D. E. and Pouyssegur, J. (2001) Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm. EMBO Rep. 2, 615-620.
10. Bhattacharya, S., Michels, C. L., Leung, M. K., Arany, Z. P., Kung, A. L. and Livingston, D. M. (1999) Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev. 13, 64-75.
11. Boyes, J., Byfield, P., Nakatani, Y. and Ogryzko, V. (1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 396, 594-598.
12. Bruick, R. K. and McKnight, S. L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
13. Bunn, H. F. and Poyton, R. O. (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev. 76, 839-885.
14. Buschmann, I. and Schaper, W. (2000) The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338-342.
15. Caniggia, I., Mostachfi, H., Winter, J., Gassmann, M., Lye, S. J., Kuliszewski, M. and Post, M. (2000) Hypoxia-inducible factor1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta (3). J. Clin. Invest. 105, 577-587.
16. Cao, Y., Linden, P., Shima, D., Browne, F. and Folkman, J. (1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98, 2507-2511.
17. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., Keshert, E. and Keshet, E. (1998) Role of HIF1alpha in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394, 485-490.
18. Carmeliet, P. and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257.
19. Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H. and Poellinger, L. (2000) Redox-regulated recruitment of the transcriptional co-activators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell Biol. 20, 402-415.
20. Chauchereau, A., Georgiakaki, M., Perrin-Wolff, M., Milgrom, E. and Loosfelt, H. (2000) JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem. 275, 8540-8548.
21. Cho, H., Kim, W. J., Lee, S. W., Kim, Y. M., Choi, E. Y., Park, S., Kwon, Y. G. and Kim, K. W. (2001) Anti-angiogenic activity of mouse N-/C-terminal deleted endostation. J. Biochem. Mol. Biol. 34, 206-211.
22. Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G. W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J. and Maxwell, P. H. (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733-25741.
23. Conway, E. M., Collen, D. and Carmeliet, P. (2001) Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507-521.
24. Cormier-Regard, S., Nguyen, S. V. and Claycomb, W. C. (1998) Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273, 17787-17792.
25. Eckhart, A. D., Yang, N., Xin, X. and Faber, J. E. (1997) Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc. Natl. Acad. Sci. USA 94, 9487-9492.
26. Ema, M., Hirota, K., Mimura, J., Abe, H., Yodoi, J., Sogawa, K., Poellinger, L. and Fujii-Kuriyama, Y. (1999) Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18, 1905-1914.
27. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., Tian, Y. M., Masson, N., Hamilton, D. L., Jaakkola, P., Barstead, R., Hodgkin, J., Maxwell, P. H., Pugh, C. W., Schofield, C. J. and Ratcliffe, P. J. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
28. Feldser, D., Agani, F., Iyer, N. V., Pak, B., Ferreira, G. and Semenza, G. L. (1999) Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 59, 3915-3918.
29. Folkman, J., Merler, E., Abernathy, C. and Williams, G. (1971) Isolation of a tumor factor responsible or angiogenesis. J. Exp. Med. 133, 275-288.
30. Gerber, H. P., Condorelli, F., Park, J. and Ferrara, N. (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Fit-1, but not Flk-1/KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23659-23667.
31. Giordano, F. J. and Johnson, R. S. (2001) Angiogenesis: the role of the microenvironment in flipping the switch. Curr. Opin. Genet. Dev. 11, 35-40.
32. Gleadle, J. M., Ebert, B. L., Firth, J. D. and Ratcliffe, P. J. (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol 268, C1362-C1368.
33. Hanahan, D., Christofori, G., Naik, P. and Arbeit, J. (1996) Transgenic mouse models of tumor angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur. J. Cancer 32A, 2386-2393.
34. Harris, A. L. (2000) von Hippel-Lindan syndrome: target for antivascular endothelial growth factor (VEGF) receptor therapy. Oncologist 5 Suppl. 1, 32-36.
35. Hewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y. M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., Ratcliffe, P. J., Pugh, C. W. and Schofield, C. J. (2002) Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
36. Hu, J., Discher, D. J., Bishopric, N. H. and Webster, K. A. (1998) Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245, 894-899.
37. Huang, L. E., Gu, J., Schau, M. and Bunn, H. F. (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95, 7987-7992.
38. Ingram, A. K., Cross, G. A. and Horn, D. (2000) Genetic manipulation indicates that ARD1 is an essential N(infinity)-acetyltransferase in Trypanosoma brucei. Mol. Biochem. Parasitol. 111, 309-317.
39. 2 sensing. Science 292, 464-468.
40. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y. and Semenza, G. L. (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12, 149-162.
41. 2-regulated prolyl hydroxylation. Science 292, 468-472.
42. Jeong, J. -W., Bae, M. -K., Ahn, M. -Y., Kim, S. -H., Shon, T. -K., Bae, M. -H., Yoo, H. -A., Song, E. J., Lee, K. -J. and Kim, K. -W. (2002) Regulation and destabilization of HIF-1 alpha by ARD1-mediated acetylation. Cell 111, 709-720..
43. Jiang, B. H., Rue, E., Wang, G. L., Roe, R. and Semenza, G. L. (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778.
44. Josko, J., Gwozdz, B., Jedrzejowska-Szypulka, H. and Hendryk, S. (2000) Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med. Sci. Monit. 6, 1047-1052.
45. Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y. and Poellinger, L. (1999) Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525.
46. Kamura, T., Sato, S., Iwai, K., Czyzyk-Krzeska, M., Conaway, R.C. and Conaway, J.W. (2000) Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA 97, 10430-10435.
47. Kietzmann, T., Roth, U. and Jungermann, K. (1999) Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-I in rat hepatocytes. Blood 94, 4177-4185.
48. Kim, K. W., Bae, S. K., Lee, O. H., Bae, M. H., Lee, M. J. and Park, B. C. (1998) Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res. 58, 348-351.
49. Kouzarides, T. (1999) Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9, 40-48.
50. Kouzarides, T. (2000) Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176-1179.
51. Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L. and Bruick, R. K. (2002a) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
52. Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J. and Whitelaw, M. L. (2002b) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
53. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C. and Semenza, G. L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell Biol. 21, 3995-4004.
54. LeCouter, J., Kowalski, J., Foster, J., Hass, P., Zhang, Z., Dillard-Telm, L., Frantz, G., Rangell, L., DeGuzman, L., Keller, G. A., Peale, F., Gurney, A., Hillan, K. J. and Ferrara, N. (2001) Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412, 877-884.
55. Lee, P. J., Jiang, B. H., Chin, B. Y., Iyer, N. V., Alam, J., Semenza, G. L. and Choi, A. M. (1997) Hypoxia-inducible factor-1 mediates transcriptional activation of the heine oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375-5381.
56. Lelievre, E., Lionneton, F., Soncin, F. and Vandenbunder, B. (2001) The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int. J. Biochem. Cell Biol. 33, 391-407.
57. Lok, C. N. and Ponka, P. (1999) Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274, 24147-24152.
58. Mahon, P. C., Hirota, K. and Semenza, G. L. (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
59. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A. and Poellinger, L. (2001) Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554.
60. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W. and Ratcliffe, P. J. (2001) Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20, 5197-5206.
61. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R. and Ratcliffe, P. J. (1999) The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
62. Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W. and Varesio, L. (1995) A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693.
63. Minet, E., Michel, G., Mottet, D., Raes, M. and Michiels, C. (2001) Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free Radic. Biol. Med. 31, 847-855.
64. Minet, E., Mottet, D., Michel, G., Roland, I., Raes, M., Remacle, J. and Michiels, C. (1999) Hypoxia-induced activation of HIF1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett. 460, 251-256.
65. Mukhopadhyay, C. K., Mazumder, B. and Fox, P. L. (2000) Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 275, 21048-21054.
66. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22.
67. Ogryzko, V. V., Kotani, T., Zhang, X., Schiltz, R. L., Howard, T., Yang, X. J., Howard, B. H., Qin, J. and Nakatani, Y. (1998) Histone-like TAFs within the PCAF histone acetylase complex. Cell 94, 35-44.
68. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T. Y., Huang, L. E., Pavletich, N., Chau, V. and Kaelin, W. G. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nature Cell Biol. 2, 423-427.
69. Oikawa, M., Abe, M., Kurosawa, H., Hida, W., Shirato, K. and Sato, Y. (2001) Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem. Biophys. Res. Commun. 289, 39-43.
70. Palmer, L. A., Semenza, G. L., Stoler, M. H. and Johns, R. A. (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am. J. Physiol 274, L212-L219.
71. Park, J. H., Park, T., Kim, H. Y. and Yang, Y. M. (2001) The IGFBP-1 mRNA experession in HepG2 cells is affected by inhibition of heme biosynthesis. J. Biochem. Mol. Biol. 34, 385-389.
72. Park, E. C. and Szostak, J. W. (1992) ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J. 11, 2087-2093.
73. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L. and Bedi, A. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 14, 34-44.
74. Rolfs, A., Kvietikova, I., Gassmann, M. and Wenger, R. H. (1997) Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272, 20055-20062.
75. Rossetti, G., Collinge, M., Bender, J. R., Molteni, R. and Pardi, R. (2002) Integrin-dependent regulation of gene expression in leukocytes. Immunol. Rev. 186, 189-207.
76. Ruas, J. L., Poellinger, L. and Pereira, T. (2002) Functional Analysis of Hypoxia-inducible Factor-1alpha-mediated Transactivation. J. Biol. Chem. 277, 38723-38730.
77. Ryan, H. E., Lo, J. and Johnson, R. S. (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005-3015.
78. Salceda, S., Beck, I., Srinivas, V. and Caro, J. (1997) Complex role of protein phosphorylation in gene activation by hypoxia. Kidney Int. 51, 556-559.
79. Salceda, S. and Caro, J. (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642-22647.
80. Schaper, W. and Buschmann, I. (1999) VEGF and therapeutic opportunities in cardiovascular diseases. Curr. Opin. Biotechnol. 10, 541-543.
81. Scholz, D., Cai, W.J. and Schaper, W. (2001) Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis. 4, 247-257.
82. Seeger, M., Kraft, R., Ferrell, K., Bech-Otschir, D., Dumdey, R., Schade, R., Gordon, C., Naumann, M. and Dubiel, W. (1998) A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J. 12, 469-478.
83. Semenza, G. L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578.
84. Semenza, G. L. (2000) Oxygen-regulated transcription factors and their role in pulmonary disease. Respir. Res. 1, 159-162.
85. Semenza, G. L. (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8, S62-S67.
86. Sutter, C. H., Laughner, E. and Semenza, G. L. (2000) Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA 97, 4748-4753.
87. Tacchini, L., Bianchi, L., Bernelli-Zazzera, A. and Cairo, G. (1999) Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific posttranscriptional regulation. J. Biol. Chem. 274, 24142-24146.
88. Tacchini, L., Dansi, P., Matteucci, E. and Desiderio, M. A. (2001) Hepatocyte growth factor signaling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22, 1363-1371.
89. Takahashi, Y., Takahashi, S., Shiga, Y., Yoshimi, T. and Miura, T. (2000) Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J. Biol. Chem. 275, 14139-14146.
90. Tanimoto, K., Makino, Y., Pereira, T. and Poellinger, L. (2000) Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindan tumor suppressor protein. EMBO J. 19, 4298-4309.
91. Tazuke, S. I., Mazure, N. M., Sugawara, J., Carland, G., Faessen, G. H., Suen, L. F., Irwin, J.C., Powell, D. R., Giaccia, A. J. and Giudice, L. C. (1998) Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc. Natl. Acad. Sci. USA 95, 10188-10193.
92. Tomoda, K., Kubota, Y. and Kato, J. (1999) Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398, 160-165.
93. Tribioli, C., Mancini, M., Plassart, E., Bione, S., Rivella, S., Sala, C., Torri, G. and Toniolo, D. (1994) Isolation of new genes in distal Xq28: transcriptional map and identification of a human homologue of the ARD1 N-acetyl transferase of Saccharomyces cerevisiae. Human Mol. Genet. 3, 1061-1067.
94. Tsukamoto, A., Kaneko, Y., Yoshida, T., Ichinose, M. and Kimura, S. (1999) Regulation of angiogenesis in human hepatomas: possible involvement of p53-inducible inhibitor of vascular endothelial cell proliferation. Cancer Lett. 141, 79-84.
95. Wang, G. L. and Semenza, G. L. (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90, 4304-4308.
96. Wood, S. M., Wiesener, M. S., Yeates, K. M., Okada, N., Pugh, C. W., Maxwell, P. H. and Ratcliffe, P. J. (1998) Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif-1alpha-dependent and -independent hypoxia-inducible gene expression. J. Biol. Chem. 273, 8360-8368.
97. Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L. and Ratcliffe, P. J. (2000) Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene 19, 6297-6305.
98. Xie, K. (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12, 375-391.
99. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W. and Semenza, G. L. (2000) Modulation of hypoxia-inducible factor lalpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545.